The Role of Exosomal Non-Coding RNAs in Coronary Artery Disease

Jia Liu1, Junduo Wu1, Longbo Li1

  • 1Department of Cardiology, The Second Hospital of Jilin University, Changchun, China.

Frontiers in Pharmacology
|December 28, 2020
PubMed

Insights

Exosomes carrying non-coding RNAs (ncRNAs) are crucial in cardiovascular disease (CVD) development. Understanding exosomal ncRNA mechanisms in atherosclerosis offers new diagnostic and therapeutic strategies for coronary artery disease (CAD).

Area of Science:

  • Biomedical Sciences
  • Molecular Biology
  • Cardiology

Background:

  • Cardiovascular disease (CVD), particularly atherosclerosis (AS), is a leading global cause of death.
  • Key factors in AS pathogenesis include oxidative stress, endothelial dysfunction, and inflammation.
  • Exosomes, nano-sized vesicles, mediate intercellular communication by transferring lipids, proteins, and RNA.

Purpose of the Study:

  • To review the role and regulatory mechanisms of exosomal non-coding RNAs (ncRNAs) in coronary artery disease (CAD) pathophysiology.
  • To explore the diagnostic and therapeutic potential of exosomal ncRNAs in CAD.

Main Methods:

  • Literature review focusing on exosomal ncRNAs in cardiovascular disease.
  • Analysis of molecular mechanisms underlying exosomal ncRNA function in atherosclerosis.
  • Synthesis of current research on exosomal ncRNA in CAD diagnosis and treatment.

Main Results:

  • Exosomal ncRNAs play a significant role in intercellular communication relevant to AS.
  • These ncRNAs can induce phenotypic changes and regulate cellular functions involved in CAD.
  • Exosomal ncRNAs are implicated in the complex pathophysiology of atherosclerosis.

Conclusions:

  • Elucidating exosomal ncRNA mechanisms provides insights into CAD development.
  • Exosomal ncRNAs represent promising biomarkers for CAD diagnosis.
  • Targeting exosomal ncRNAs offers potential therapeutic strategies for cardiovascular disease.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
676
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
202
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.1K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.2K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
479